Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

10.1016/S0168-8278(99)80393-6

10.1016/S0168-8278(99)80154-8

10.1136/gut.49.suppl_1.I1

2000, Can J Gastroenterol, 14, 5B, 10.1155/2000/309605

10.1053/gast.1996.v111.pm8898645

10.1016/S0140-6736(98)07124-4

10.1056/NEJM199811193392101

10.1053/jhep.2001.21747

10.1056/NEJM200012073432301

10.1056/NEJM200012073432302

10.1053/jhep.2001.26371

Pockros PJ, Carithers R, Desmond P, et al. Evaluation of two doses of peginterferon alfa-2a for the treatment of chronic hepatitis C (CHC). In: Program and abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, December 16–19, 2001. Washington, D.C.: American Society for Microbiology, 2002:285. abstract.

10.1016/S0140-6736(01)06102-5

10.1002/hep.510280302

10.1016/S0009-9236(96)90003-X

10.2165/00003088-199019050-00003

Algranati NE, 1999, Hepatology, 30, 190A

Germer JJ, 1999, J Clin Microbiol, 37, 2625, 10.1128/JCM.37.8.2625-2630.1999

10.1093/biomet/63.3.655

10.1002/sim.4780100609

Breslow NE, Day NE. Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. Lyons, France: International Agency for Research on Cancer, 1980. (IARC scientific publications no. 32.)

10.1053/jhep.2001.28706